Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 2, 2026

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

Minimization protocols in pancreas transplantation.

Diego Cantarovich1, Fabio Vistoli

  • 1Institut de Transplantation et de Recherche en Transplantation, Nantes University Hospital, France. diego.cantarovich@chu-nantes.fr

Transplant International : Official Journal of the European Society for Organ Transplantation
|August 21, 2008
PubMed
Summary

Diagnosing pancreas transplant injury is challenging. Current immunosuppression, including calcineurin inhibitors (CNI) and corticosteroids, can cause hyperglycemia, complicating diagnosis and patient care. New strategies are needed.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Banff 2024 Pancreas Transplantation Report: Diagnosis and impact of chronic active T cell-mediated allograft rejection and re-evaluation of the indeterminate category with utilization of leukocyte immunostains in biopsies with ambiguous findings.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Designing a national network of pancreas units: the Italian model for high-quality pancreatic cancer care.

Updates in surgery·2026
Same author

Psychometric Validation of Questionnaire on Knowledge and Attitudes Towards Organ Donation and Transplantation (Donors Preliminary Study).

Transplantation proceedings·2026
Same author

Towards environmentally sustainable surgery: a comparison of robotic surgery with other approaches.

Updates in surgery·2026
Same author

Anti-AT1R autoantibodies in pancreas transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Response to the Letter to the Editor Entitled "Refining Approaches to Fibrosis Control in Kidney Transplant Recipients".

Kidney international reports·2025

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pharmacology

Background:

  • Diagnosing immunologic injury in pancreas transplants is complex compared to other organs.
  • Current immunosuppressive regimens (calcineurin inhibitors, antimetabolites, corticosteroids) are non-specific and can induce hyperglycemia, complicating diagnosis.
  • Pancreas transplant outcomes now rival kidney and liver transplants, increasing focus on long-term quality of life and graft function.

Purpose of the Study:

  • To review the challenges in diagnosing immunologic injury in pancreas transplantation.
  • To evaluate the impact of current immunosuppressive regimens on pancreas transplant recipients, particularly regarding hyperglycemia.
  • To explore alternative immunosuppressive agents and weaning strategies to improve patient outcomes.

Main Methods:

More Related Videos

A Simple High Efficiency Protocol for Pancreatic Islet Isolation from Mice
06:56

A Simple High Efficiency Protocol for Pancreatic Islet Isolation from Mice

Published on: August 30, 2019

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Related Experiment Videos

Last Updated: Jul 2, 2026

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

A Simple High Efficiency Protocol for Pancreatic Islet Isolation from Mice
06:56

A Simple High Efficiency Protocol for Pancreatic Islet Isolation from Mice

Published on: August 30, 2019

Isolation of Human Islets from Partially Pancreatectomized Patients
11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

  • Review of current immunosuppressive protocols for pancreas transplantation.
  • Discussion of the diabetogenic effects of calcineurin inhibitors and corticosteroids.
  • Exploration of alternative immunosuppressive agents (e.g., sirolimus, everolimus) and their potential benefits.

Main Results:

  • Calcineurin inhibitors and corticosteroids can induce hyperglycemia, mimicking or exacerbating rejection.
  • Minimizing or avoiding these drugs carries a risk of graft loss, necessitating careful management.
  • Newer agents like sirolimus and everolimus show promise as less diabetogenic and nephrotoxic alternatives.

Conclusions:

  • Optimizing immunosuppression in pancreas transplantation is crucial for long-term graft survival and patient quality of life.
  • Further large-scale randomized trials are essential to establish new guidelines for immunosuppressive regimens.
  • Balancing effective immunosuppression with minimizing side effects like hyperglycemia is a key challenge.